The role of dexamethasone in the treatment of bacterial meningitis - A systematic review

Acta Anaesthesiologica Scandinavica

Volumn 56, Issue 10, 2012, Pages 1210-1221

  Borchorst, S ^a   Moller K ^b  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; DEXAMETHASONE; METHYLPREDNISOLONE; PLACEBO;

BACTERIAL COLONIZATION; BACTERIAL MENINGITIS; BACTERIAL VIRULENCE; BIBLIOGRAPHIC DATABASE; BLOOD BRAIN BARRIER; BRAIN BLOOD VESSEL; BRAIN EDEMA; CELL ACTIVATION; CEREBROSPINAL FLUID; COCHRANE LIBRARY; DEVELOPED COUNTRY; DEVELOPING COUNTRY; DISEASE ASSOCIATION; DRUG FATALITY; HAEMOPHILUS INFLUENZAE; HEARING IMPAIRMENT; HUMAN; INTRACRANIAL PRESSURE; MEDLINE; META ANALYSIS; META ANALYSIS (TOPIC); MORTALITY; NEISSERIA MENINGITIDIS; NONHUMAN; PATHOGENESIS; PNEUMOCOCCAL MENINGITIS; PRIORITY JOURNAL; PUBLICATION; QUASI EXPERIMENTAL STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; REVIEW; RISK FACTOR; STREPTOCOCCUS PNEUMONIAE; SYSTEMATIC REVIEW; SYSTEMATIC REVIEW (TOPIC);

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; CHILD; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; DEXAMETHASONE; FEMALE; HUMANS; MALE; MENINGITIS, BACTERIAL; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84867582893     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2012.02698.x     Document Type: Review

References (84)

1. Brouwer MC, Tunkel AR, van de, Beek D,. Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clin Microbiol Rev 2010; 23: 467-492.
2. van de Beek D, Schmand B, de, Gans J, Weisfelt M, Vaessen H, Dankert J, Vermeulen M,. Cognitive impairment in adults with good recovery after bacterial meningitis. J Infect Dis 2002; 186: 1047-1052.
3. Tunkel AR, Scheld WM,. Pathogenesis and pathophysiology of bacterial meningitis. Clin Microbiol Rev 1993; 6: 118-136.
4. Moxon ER, Ostrow PT,. Haemophilus influenzae meningitis in infant rats: role of bacteremia in pathogenesis of age dependent inflammatory responses in cerebrospinal fluid. J Infect Dis 1977; 135: 303-307.
5. Cundell DR, Gerard NP, Gerard C, Idanpaan-Heikkila I, Tuomanen EI,. Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature 1995; 377: 435-438.
6. Quagliarello VJ, Long WJ, Scheld WM,. Morphologic alterations of the blood-brain barrier with experimental meningitis in the rat. Temporal sequence and role of encapsulation. J Clin Invest 1986; 77: 1084-1095.
7. Mook-Kanamori BB, Geldhoff M, van der, Poll T, van de, Beek D,. Pathogenesis and pathophysiology of pneumococcal meningitis. Clin Microbiol Rev 2011; 24: 557-591.
8. Saukkonen K, Sande S, Cioffe C, Wolpe S, Sherry B, Cerami A, Tuomanen E,. The role of cytokines in the generation of inflammation and tissue damage in experimental gram-positive meningitis. J Exp Med 1990; 171: 439-448.
9. Quagliarello VJ, Wispelwey B, Long WJ, Scheld WM,. Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat. Characterization and comparison with tumor necrosis factor. J Clin Invest 1991; 87: 1360-1366.
10. Scheld WM, Koedel U, Nathan B, Pfister HW,. Pathophysiology of bacterial meningitis: mechanism(s) of neuronal injury. J Infect Dis 2002; 186 (Suppl. 2): S225-233.
11. Koedel U, Scheld WM, Pfister HW,. Pathogenesis and pathophysiology of pneumococcal meningitis. Lancet Infect Dis 2002; 2: 721-736.
12. Täuber MG, Khayam-Bashi H, Sande MA,. Effects of ampicillin and corticosteroids on brain water content, cerebrospinal fluid pressure, and cerebrospinal fluid lactate levels in experimental pneumococcal meningitis. J Infect Dis 1985; 151: 528-534.
13. Tuomanen E, Hengstler B, Rich R, Bray MA, Zak O, Tomasz A,. Nonsteroidal anti-inflammatory agents in the therapy for experimental pneumococcal meningitis. J Infect Dis 1987; 155: 985-990.
14. Syrogiannopoulos GA, Olsen KD, Reisch JS, McCracken GH,. Dexamethasone in the treatment of experimental Haemophilus influenzae type b meningitis. J Infect Dis 1987; 155: 213-219.
15. Koedel U, Pfister HW, Tomasz A,. Methylprednisolone attenuates inflammation, increase of brain water content and intracranial pressure, but does not influence cerebral blood flow changes in experimental pneumococcal meningitis. Brain Res 1994; 644: 25-31.
16. Mustafa MM, Ramilo O, Mertsola J, Risser RC, Beutler B, Hansen EJ, McCracken GH,. Modulation of inflammation and cachectin activity in relation to treatment of experimental Hemophilus influenzae type b meningitis. J Infect Dis 1989; 160: 818-825.
17. Kadurugamuwa JL, Hengstler B, Zak O,. Cerebrospinal fluid protein profile in experimental pneumococcal meningitis and its alteration by ampicillin and anti-inflammatory agents. J Infect Dis 1989; 159: 26-34.
18. Kim HH, Addison J, Suh E, Trune DR, Richter CP,. Otoprotective effects of dexamethasone in the management of pneumococcal meningitis: an animal study. Laryngoscope 2007; 117: 1209-1215.
19. Worsøe L, Brandt CT, Lund SP, Ostergaard C, Thomsen J, Cayé-Thomasen P,. Systemic steroid reduces long-term hearing loss in experimental pneumococcal meningitis. Laryngoscope 2010; 120: 1872-1879.
20. Tuomanen E, Tomasz A, Hengstler B, Zak O,. The relative role of bacterial cell wall and capsule in the induction of inflammation in pneumococcal meningitis. J Infect Dis 1985; 151: 535-540.
21. Tuomanen E, Liu H, Hengstler B, Zak O, Tomasz A,. The induction of meningeal inflammation by components of the pneumococcal cell wall. J Infect Dis 1985; 151: 859-868.
22. Nau R, Eiffert H,. Modulation of release of proinflammatory bacterial compounds by antibacterials: potential impact on course of inflammation and outcome in sepsis and meningitis. Clin Microbiol Rev 2002; 15: 95-110.
23. Blaser C, Wittwer M, Grandgirard D, Leib SL,. Adjunctive dexamethasone affects the expression of genes related to inflammation, neurogenesis and apoptosis in infant rat pneumococcal meningitis. PLoS ONE 2011; 6: e17840.
24. Bennett IL, Finland M, Hamburger M, Kass EH, Lepper M, Waisbren BA,. The effectiveness of hydrocortisone in the management of severe infections. JAMA 1963; 183: 462-465.
25. Belsey MA, Hoffpauir CW, Smith MH,. Dexamethasone in the treatment of acute bacterial meningitis: the effect of study design on the interpretation of results. Pediatrics 1969; 44: 503-513.
26. DeLemos RA, Haggerty RJ,. Corticosteroids as an adjunct to treatment in bacterial meningitis. A controlled clinical trial. Pediatrics 1969; 44: 30-34.
27. Bademosi O, Osuntokun BO,. Prednisolone in the treatment of pneumococcal meningitis. Trop Geogr Med 1979; 31: 53-56.
28. Lebel MH, Freij BJ, Syrogiannopoulos GA, Chrane DF, Hoyt MJ, Stewart SM, Kennard BD, Olsen KD, McCracken GH,. Dexamethasone therapy for bacterial meningitis. Results of two double-blind, placebo-controlled trials. N Engl J Med 1988; 319: 964-971.
29. Lebel MH, Hoyt MJ, Waagner DC, Rollins NK, Finitzo T, McCracken GH,. Magnetic resonance imaging and dexamethasone therapy for bacterial meningitis. Am J Dis Child 1989; 143: 301-306.
30. Girgis NI, Farid Z, Mikhail IA, Farrag I, Sultan Y, Kilpatrick ME,. Dexamethasone treatment for bacterial meningitis in children and adults. Pediatr Infect Dis J 1989; 8: 848-851.
31. Odio CM, Faingezicht I, Paris M, Nassar M, Baltodano A, Rogers J, Sáez-Llorens X, Olsen KD, McCracken GH,. The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. N Engl J Med 1991; 324: 1525-1531.
32. Schaad UB, Wedgwood J, Lips U, Gnehm HE, Heinzer I, Blumberg A,. Dexamethasone therapy for bacterial meningitis in children. Lancet 1993; 342: 457-461.
33. Syrogiannopoulos GA, Lourida AN, Theodoridou MC, Pappas IG, Babilis GC, Economidis JJ, Zoumboulakis DJ, Beratis NG, Matsaniotis NS,. Dexamethasone therapy for bacterial meningitis in children: 2- versus 4-day regimen. J Infect Dis 1994; 169: 853-858.
34. Wald ER, Kaplan SL, Mason EO Jr, Sabo D, Ross LR, Arditi M, Wiedermann BL, Barson W, Kim KS, Yogev R, Hofkosh D,. Dexamethasone therapy for children with bacterial meningitis. Pediatrics 1995; 95: 21-28.
35. King SM, Law B, Heurter H, Bremner D, Wang EE,. Dexamethasone therapy for bacterial meningitis: better never than late? Can J Infect Dis 1994; 5: 210-215.
36. Kanra G, Ozen H, Seçmeer G, Ceyhan M, Ecevit Z, Belgin E,. Beneficial effects of dexamethasone in children with pneumococcal meningitis. Pediatr Infect Dis J 1995; 14: 490-494.
37. Kilpi T, Peltola H, Jauhiainen T, Kallio MJ,. Oral glycerol and intravenous dexamethasone in preventing neurologic and audiologic sequelae of childhood bacterial meningitis. The Finnish Study Group. Pediatr Infect Dis J 1995; 14: 270-278.
38. Ciana G, Parmar N, Antonio C, Pivetta S, Tamburlini G, Cuttini M,. Effectiveness of adjunctive treatment with steroids in reducing short-term mortality in a high-risk population of children with bacterial meningitis. J Trop Pediatr 1995; 41: 164-168.
39. Qazi SA, Khan MA, Mughal N, Ahmad M, Joomro B, Sakata Y, Kuriya N, Matsuishi T, Abbas KA, Yamashita F,. Dexamethasone and bacterial meningitis in Pakistan. Arch Dis Child 1996; 75: 482-488.
40. Shembesh NM, Elbargathy SM, Kashbur IM, Rao BN, Mahmoud KS,. Dexamethasone as an adjunctive treatment of bacterial meningitis. Indian J Pediatr 1997; 64: 517-522.
41. Bhaumik S, Behari M,. Role of dexamethasone as adjunctive therapy in acute bacterial meningitis in adults. Neurol India 1998; 46: 225-228.
42. Thomas R, Le Tulzo Y, Bouget J, Camus C, Michelet C, Le Corre P, Bellissant E,. Trial of dexamethasone treatment for severe bacterial meningitis in adults. Intensive Care Med 1999; 25: 475-480.
43. Molyneux EM, Walsh AL, Forsyth H, Tembo M, Mwenechanya J, Kayira K, Bwanaisa L, Njobvu A, Rogerson S, Malenga G,. Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial. Lancet 2002; 360: 211-218.
44. de Gans J, van de Beek D,. Dexamethasone in adults with bacterial meningitis. N Engl J Med 2002; 347: 1549-1556.
45. Weisfelt M, Hoogman M, van de, Beek D, de, Gans J, Dreschler WA, Schmand BA,. Dexamethasone and long-term outcome in adults with bacterial meningitis. Ann Neurol 2006; 60: 456-468.
46. Nguyen TH, Tran TH, Thwaites G, Ly VC, Dinh XS, Ho Dang TN, Dang QT, Nguyen DP, Nguyen HP, To SD, Nguyen VC, Nguyen MD, Campbell J, Schultsz C, Parry C, Torok ME, White N, Nguyen TC, Tran TH, Stepniewska K, Farrar JJ,. Dexamethasone in Vietnamese adolescents and adults with bacterial meningitis. N Engl J Med 2007; 357: 2431-2440.
47. Peltola H, Roine I, Fernández J, Zavala I, Ayala SG, Mata AG, Arbo A, Bologna R, Miño G, Goyo J, Lõpez E, de, Andrade SD, Sarna S,. Adjuvant glycerol and/or dexamethasone to improve the outcomes of childhood bacterial meningitis: a prospective, randomized, double-blind, placebo-controlled trial. Clin Infect Dis 2007; 45: 1277-1286.
48. Scarborough M, Gordon SB, Whitty CJ, French N, Njalale Y, Chitani A, Peto TE, Lalloo DG, Zijlstra EE,. Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa. N Engl J Med 2007; 357: 2441-2450.
49. Sankar J, Singhi P, Bansal A, Ray P, Singhi S,. Role of dexamethasone and oral glycerol in reducing hearing and neurological sequelae in children with bacterial meningitis. Indian Pediatr 2007; 44: 649-656.
50. Tolaj I, Dreshaj S, Qehaja E, Tolaj J, Doda-Ejupi T, Mehmeti M,. Dexamethasone as adjuvant therapy in the treatment of invasive meningococcal diseases. Med Arh 2010; 64: 228-230.
51. Nguyen TH, Tuan TV, Wolbers M, Hoang DM, Nga TV, Chau TT, Chuong LV, Sinh DX, Nghia HD, Phong ND, Phu NH, Diep TS, Hang HT, Chau NV, Farrar J, Schultsz C, Hien TT, Simmons CP,. Immunological and biochemical correlates of adjunctive dexamethasone in Vietnamese adults with bacterial meningitis. Clin Infect Dis 2009; 49: 1387-1392.
52. Peltola H, Roine I, Fernández J, González Mata A, Zavala I, Gonzalez Ayala S, Arbo A, Bologna R, Goyo J, Lõpez E, Miño G, Dourado de Andrade S, Sarna S, Jauhiainen T,. Hearing impairment in childhood bacterial meningitis is little relieved by dexamethasone or glycerol. Pediatrics 2010; 125: e1-8.
53. Lepper MH, Spies HW,. The use of intravenous hydrocortisone as supplemental treatment in acute bacterial meningitis; an alternate case study. Antibiot Annu 1957; 5: 336-349.
54. Lepper MH, Spies HW,. Treatment of pneumococcic meningitis; results when penicillin was used alone compared with those when penicillin and streptomycin were used together, with and without hydrocortisone: alternate patient studies. AMA Arch Intern Med 1959; 104: 253-259.
55. Jensen K, Ranek L, Rosdahl N,. Bacterial meningitis; a review of 356 cases with special reference to corticosteroid and antiserum treatment. Scand J Infect Dis 1969; 1: 21-30.
56. Baldy JL, Passos JN,. Dexametasona no tratamento da meningite meningocõcica. Rev Paul Med 1986; 104: 61-65.
57. Marguet C, Mallet E,. Intérêt de la dexaméthasone au cours des méningites purulentes de l'enfant: a propos d'une étude comparative chez 85 enfants. Arch Fr Pediatr 1993; 50: 111-117.
58. Gupta A, Singh NK,. Dexamethasone in adults with bacterial meningitis. J Assoc Physicians India 1996; 44: 90-92.
59. Daoud AS, Batieha A, Al-Sheyyab M, Abuekteish F, Obeidat A, Mahafza T,. Lack of effectiveness of dexamethasone in neonatal bacterial meningitis. Eur J Pediatr 1999; 158: 230-233.
60. Gijwani D, Kumhar MR, Singh VB, Chadda VS, Soni PK, Nayak KC, Gupta BK,. Dexamethasone therapy for bacterial meningitis in adults: a double blind placebo control study. Neurol India 2002; 50: 63-67.
61. Ahsan T, Shahid M, Mahmood T, Jabeen R, Jehangir U, Saleem M, Ahmed N, Shaheer A,. Role of dexamethasone in acute bacterial meningitis in adults. J Pak Med Assoc 2002; 52: 233-239.
62. Ayaz C, Celen MK, Geyik MF, Ulug M,. The efficacy of dexamethasone treatment in adult patients with acute bacterial meningitis. Neurosciences 2008; 13: 146-150.
63. Kennedy WA, Hoyt MJ, McCracken GH,. The role of corticosteroid therapy in children with pneumococcal meningitis. Am J Dis Child 1991; 145: 1374-1378.
64. Macaluso A, Pivetta S, Maggi RS, Tamburlini G, Cattaneo A,. Dexamethasone adjunctive therapy for bacterial meningitis in children: a retrospective study in Brazil. Ann Trop Paediatr 1996; 16: 193-198.
65. Arditi M, Mason EO Jr, Bradley JS, Tan TQ, Barson WJ, Schutze GE, Wald ER, Givner LB, Kim KS, Yogev R, Kaplan SL,. Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use. Pediatrics 1998; 102: 1087-1097.
66. Brouwer MC, Heckenberg SG, de, Gans J, Spanjaard L, Reitsma JB, van de, Beek D,. Nationwide implementation of adjunctive dexamethasone therapy for pneumococcal meningitis. Neurology 2010; 75: 1533-1539.
67. Peterković V, Trkulja V, Kutleša M, Krajinović V, Lepur D,. Dexamethasone for adult community-acquired bacterial meningitis: 20 years of experience in daily practice. J Neurol 2012; 259: 225-236.
68. Havens PL, Wendelberger KJ, Hoffman GM, Lee MB, Chusid MJ,. Corticosteroids as adjunctive therapy in bacterial meningitis. Am J Dis Child 1989; 143: 1051-1055.
69. Geiman BJ, Smith AL,. Dexamethasone and bacterial meningitis. A meta-analysis of randomized controlled trials. West J Med 1992; 157: 27-31.
70. Yurkowski PJ, Plaisance KI,. Prevention of auditory sequelae in pediatric bacterial meningitis: a meta-analysis. Pharmacotherapy 1993; 13: 494-499.
71. McIntyre PB, Berkey CS, King SM, Schaad UB, Kilpi T, Kanra GY, Perez CM,. Dexamethasone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomized clinical trials since 1988. JAMA 1997; 278: 925-931.
72. van de Beek D, de Gans J, McIntyre P, Prasad K,. Steroids in adults with acute bacterial meningitis: a systematic review. Lancet Infect Dis 2004; 4: 139-143.
73. van de Beek D, de Gans J, McIntyre P, Prasad K,. Corticosteroids for acute bacterial meningitis (Review). Cochrane Database Syst Rev 2007; (1): CD004405.
74. Vardakas KZ, Matthaiou DK, Falagas ME,. Adjunctive dexamethasone therapy for bacterial meningitis in adults: a meta-analysis of randomized controlled trials. Eur J Neurol 2009; 16: 662-673.
75. Assiri AM, Alasmari FA, Zimmerman VA, Baddour LM, Erwin PJ, Tleyjeh IM,. Corticosteroid administration and outcome of adolescents and adults with acute bacterial meningitis: a meta-analysis. Mayo Clin Proc 2009; 84: 403-409.
76. van de Beek D, Farrar JJ, de, Gans J, Mai NT, Molyneux EM, Peltola H, Peto TE, Roine I, Scarborough M, Schultsz C, Thwaites GE, Tuan PQ, Zwinderman AH,. Adjunctive dexamethasone in bacterial meningitis: a meta-analysis of individual patient data. Lancet Neurol 2010; 9: 254-263.
77. Brouwer MC, McIntyre P, de, Gans J, Prasad K, van de, Beek D,. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev 2010; (9): CD004405.
78. Leib SL, Heimgartner C, Bifrare YD, Loeffler JM, Täauber MG,. Dexamethasone aggravates hippocampal apoptosis and learning deficiency in pneumococcal meningitis in infant rats. Pediatr Res 2003; 54: 353-357.
79. Newcomer JW, Craft S, Hershey T, Askins K, Bardgett ME,. Glucocorticoid-induced impairment in declarative memory performance in adult humans. J Neurosci 1994; 14: 2047-2053.
80. Edmond K, Clark A, Korczak VS, Sanderson C, Griffiths UK, Rudan I,. Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis. Lancet Infect Dis 2010; 10: 317-328.
81. Chan ED, Ong CW, Hsu LY, Tambyah PA, Taha MK, Alonso JM, Siberry GK, McMillan JA, Mai NTH, Thwaites G, Farrar JJ, Scarborough M, Gordon S, Peto T,. Corticosteroids for bacterial meningitis. N Engl J Med 2008; 358: 1399-1401.
82. Viladrich PF, Gudiol F, Linares J, Pallares R, Sabate I, Rufi G, Ariza J,. Evaluation of vancomycin for therapy of adult pneumococcal meningitis. Antimicrob Agents Chemother 1991; 35: 2467-2472.
83. Schut ES, Brouwer MC, de, Gans J, Florquin S, Troost D, van de, Beek D,. Delayed cerebral thrombosis after initial good recovery from pneumococcal meningitis. Neurology 2009; 73: 1988-1995.
84. Woehrl B, Brouwer MC, Murr C, Heckenberg SG, Baas F, Pfister HW, Zwinderman AH, Morgan BP, Barnum SR, van der, Ende A, Koedel U, van de, Beek D,. Complement component 5 contributes to poor disease outcome in humans and mice with pneumococcal meningitis. J Clin Invest 2011; 121: 3943-3953.